SCHEMBL19080126

SCHEMBL19080126

c1cc(-c2ccc3c4ccccc4c4c(oc5c6ccccc6c6ccccc6c54)c3c2)cc(-c2c3ccccc3c(-c3ccc(-c4cccc5ccccc45)cc3)c3ccccc23)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 4/20 0.40
CA1 P00915 4/20 0.40
CA2 P00918 4/20 0.40
CA9 Q16790 4/20 0.40
ENPP3 O14638 1/20 0.36
ENPP1 P22413 1/20 0.36
HDAC8 Q9BY41 1/20 0.35
HDAC6 Q9UBN7 1/20 0.35
KDM4E B2RXH2 2/20 0.34
ALDH1A1 P00352 2/20 0.34
ATM Q13315 2/20 0.34
HSD17B10 Q99714 2/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2C19 P33261 1/20 0.34
RAB9A P51151 1/20 0.34
MCL1 Q07820 1/20 0.33
ACMSD Q8TDX5 1/20 0.33
ARSA P15289 1/20 0.33
CDC25A P30304 1/20 0.33
CDC25C P30307 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19079982 0.94 CA12 (0.36) CA12CA1CA2CA9KDM4E
SCHEMBL19079946 0.88 PLA2G2A (0.40) CA12CA1CA2CA9KDM4E
SCHEMBL16067667 0.88 CA12 (0.39) CA12CA1CA2CA9ENPP3
SCHEMBL16068045 0.88 CA12 (0.39) CA12CA1CA2CA9ENPP3
SCHEMBL19080120 0.87 CA12 (0.37) CA12CA1CA2CA9ENPP3
SCHEMBL19080141 0.87 PLA2G2A (0.36) PLA2G10PLA2G2APLA2G4A
SCHEMBL19079969 0.87 CA12 (0.36) CA12CA1CA2CA9KDM4E
SCHEMBL19080118 0.87 AHR (0.37) CA12CA1CA2CA9CYP1A2
SCHEMBL24652280 0.86 CA12 (0.34) CA12CA1CA2CA9ENPP3
SCHEMBL19080014 0.86 CYP1A1 (0.40) KDM4EALDH1A1HSD17B10CYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10580999-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-03-03 US disclosed
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNA1 CA12 1347/4885CA1 1453/4885CA2 2870/4885
US-10580999-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNA1 CA12 1347/4885CA1 1453/4885CA2 2870/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.